LATEST WEBINARS
Webinar live date: Thursday 10 January 2018 07:00 [PST] 10:00 [EST] 15:00 [GMT]. In this free panel discussion, our experts will provide insights into their own research with immunogenicity including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field.
Webinar live date: Tuesday 8 January 2019 07:00 [PST] 10:00 [EST] 15:00 [GMT]. Exploring the challenges a lack of industry standardization presents for CRO project managers and scientists as well as biopharma and biotech companies.
Webinar available to view on demand. Learn how a standardized approach for the bioanalysis of biotherapeutics by hybrid LC–MS is applied in a contract research environment, whilst also considering compliance with regulatory requirements.
Webinar available to view on demand. Methods for the detection of drug-induced antibodies have become much more sensitive, but the question remains to be answered: are antibodies at this low concentration level clinically relevant?
Webinar available to view on demand. In this webinar, our Bioanalysis Zone Rising Star Award winner, Jing Tu (PPD; VA, USA), will introduce a systematic approach that allows efficient and consistent ligand binding based bioanalytical method development.
Webinar available to view on demand. This webinar talks about the benefit of incorporating microsampling techniques in bioanalytical assays, as well as the effort required to overcome the challenges.
Webinar available to view on demand. Accurate and precise biomarker measurement is critical to identifying diagnostic markers and druggable targets. Learn how quantitative mass spectrometry ensures proper biomarker measurement and characterization.
Webinar available to view on demand. Thursday 27 September 2018. In this webinar, learn about utilizing xMAP® technology coupled with machine learning algorithms to detect polyps and early-stage colorectal cancer
Latest News
Thermo Fisher Scientific (MA, USA) have announced the launch of a new complementary diagnostic immunoassay, the Thermo Scientific QMS Plazomicin Immunoassay, for measuring the concentration of a novel therapeutic antibiotic, plazomicin, used to treat complicated urinary tract infections.
From the quantification and validation of biomarkers to the integration of novel technology in bioanalytical workflows, as the year comes to a close we’re looking back on the bioanalytical highlights from 2018.
Researchers from the University of Queensland (Australia) have discovered a unique biomarker common to multiple cancers that has the potential to change the way early stage cancer is diagnosed.
Latest Features
In this conference report we discuss our highlights from the 11th Open Meeting of the European Bioanalytical Forum – Raise the Anchor, Set Sail for Science (Barcelona, Spain; 21–23 November).
Find out more an electrochemiluminescent bridging immunogenicity assay used to measure anti-drug antibodies in human serum using an acid dissociation step in this poster from KCAS Bioanalytical & Biomarker Services (KS, USA).
All immunogenicity assessments present specific challenges. As a contract research organization (CRO), a major challenge we face is related to the lack of harmonization and standardization. Find out more in this editorial from a team at LGC (Cambridgeshire, UK).
Drug Discovery and Development
Chip off the old block: novel lab-on-a-chip techniques for R&D
Ligand-binding
Hybrid assays: the next big thing?
Evolution of fit-for-purpose biomarker validations: an LBA perspective
Mass Spectrometry
Solvent and additive purity selections in bioanalytical LC–MS
Sample preparation, extraction & collection
In the Zone: alternative matrices
Noninvasive method potentially as effective at measuring blood glucose as finger prick test
Nanopore system offers real-time single molecule analysis of complex biological samples